Hong Kong WD Pharmaceutical

Hong Kong WD Pharmaceutical Co., Limited is an innovative drug delivery system developer with global independent intellectual property rights, focusing on the 505(b)(2) new drug delivery system development model. Its product development cycle is short, with low investment and high R&D success rates. Currently, Hong Kong WD Pharmaceutical has developed five drug delivery systems: an upper gastrointestinal tract targeted controlled-release absorption system, pediatric and geriatric drug delivery systems, poorly soluble drug delivery systems, self-emulsifying drug delivery systems, and an osmotic pump formulation industrialization platform.